Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2024-04-26 EDT 5-day change 1st Jan Change
375.3 USD +0.59% Intraday chart for Intuitive Surgical, Inc. +2.45% +11.26%
Sales 2024 * 8.03B 10.97B Sales 2025 * 9.3B 12.72B Capitalization 133B 182B
Net income 2024 * 1.96B 2.68B Net income 2025 * 2.27B 3.1B EV / Sales 2024 * 15.9 x
Net cash position 2024 * 5.19B 7.1B Net cash position 2025 * 7.75B 10.6B EV / Sales 2025 * 13.5 x
P/E ratio 2024 *
68.1 x
P/E ratio 2025 *
59.3 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.59%
1 week+2.45%
Current month-5.95%
1 month-5.61%
3 months+0.15%
6 months+44.63%
Current year+11.26%
More quotes
1 week
364.31
Extreme 364.31
383.62
1 month
364.17
Extreme 364.17
402.50
Current year
320.26
Extreme 320.26
403.76
1 year
254.85
Extreme 254.85
403.76
3 years
180.07
Extreme 180.07
403.76
5 years
120.17
Extreme 120.1667
403.76
10 years
38.50
Extreme 38.4956
403.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 66 07-10-18
Director/Board Member 71 10-03-31
More insiders
Date Price Change Volume
24-04-26 375.3 +0.59% 927,845
24-04-25 373.1 -0.50% 1,262,618
24-04-24 375 -0.55% 1,325,633
24-04-23 377.1 +2.21% 1,858,757
24-04-22 368.9 +0.71% 1,603,144

Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
375.3 USD
Average target price
420.3 USD
Spread / Average Target
+11.98%
Consensus